-+ 0.00%
-+ 0.00%
-+ 0.00%

MACROGENICS - GILEAD SCIENCES EXERCISES OPTION FOR EXCLUSIVE LICENSE FOR A PRECLINICAL BISPECIFIC PROGRAM, TRIGGERS $10 MLN PAYMENT TO MACROGENICS

Reuters·08/11/2026 20:06:08

Please log in to view news